BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nonin Medical, Inc. Announces FDA 510(k) Clearance Expanded Labeling for Onyx® Vantage 9590 Professional Fingertip Pulse Oximeter at American Thoracic Society Annual Meeting


5/22/2012 6:46:01 AM

MINNEAPOLIS, May 21, 2012 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced commercial release with expanded labeling claims for its Onyx® Vantage 9590 professional fingertip pulse oximeter. The new labeling allows the Onyx Vantage to be used on thumbs and toes an addition to a previous indication for fingertips on pediatric through adult patients whose digit diameters range from 0.3 inches to 1.0 inches. Nonin Medical made the announcement at the American Thoracic Society (ATS) 2012 Annual Meeting in San Francisco. The Onyx Vantage accurately captures oxygen saturation (SpO2) and pulse rate measurements even in the presence of low perfusion and dark skin pigmentation. It is the first and only fingertip pulse oximeter with accuracy claims for expanded use on thumbs and toes.

"Nonin's Onyx brand of professional finger pulse oximeters is already proven accurate in the widest range of patients and settings," said Kevin McGowan, vice president, global sales, for Nonin Medical. "With this expanded indication, clinicians will now be able to use Nonin's newest professional pulse oximeter, the Onyx Vantage 9590, on fingers, thumbs or toes. This gives them even more flexibility to obtain accurate readings on a wide range of patients from pediatrics through adults.

"No longer will clinicians have to trade flexibility for peace of mind," McGowan added. "That's because, regardless of which digit they use, they can be assured that they are getting accurate readings for improved decision making that may lead to earlier intervention and better outcomes."

The Onyx Vantage finger pulse oximeter is engineered with Nonin Medical's clinically proven PureSAT pulse oximetry technology the same accurate technology used in its full line of oximeters. Peer-reviewed articles about Nonin's proven accuracy can be found online at www.onyxvantage.com.

The Onyx Vantage 9590, along with Nonin's complete line of professional wrist-worn, handheld and tabletop pulse oximeters, sensors and capnographs, can be viewed at Nonin Medical Booth #516, Moscone Center, San Francisco, during ATS Annual Meeting exhibit hours on Monday, May 21, from 10am-3pm, and Tuesday, May 22, from 10am-3pm.

About Nonin Medical, Inc.
Nonin Medical, Inc. invented fingertip and wireless fingertip pulse oximetry and is a leader in noninvasive medical monitoring. Headquartered in Minneapolis, Minn., USA, with an additional service center in Hudiksvall, Sweden, Nonin Medical designs and manufactures noninvasive pulse oximeters, regional oximeters, capnographs, sensors, software and accessories globally. The company sells its products to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide.

As a founding member of the Continua Alliance and a Bluetooth SIG CES Award winner, Nonin Medical is dedicated to developing low power, interoperable technology to reduce healthcare costs and improve quality of life. Since certifying the world's first Continua-certified product in 2009, the company continues to lead the industry in simplifying the exchange of healthcare information while driving global connectivity standards and adding interoperable solutions across its product line. For more information, visit www.nonin.com.

SOURCE Nonin Medical, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES